Search Results
Sep 10, 2026, 10:05 ET ELEVATING THE PROFESSION: THE CRUCIAL ROLE OF TRAINING AND LICENSING FOR ADJUSTERS
allowing insurance professionals to focus on their clients and their businesses", said Elaine Gulino-Founder & CEO.A great adjuster, however, doesn't stop at licensing. Education and training are key components in being a recognized professional in this space. On average, highly experienced catastrophic
More news about: Seen & Heard LLC dba License Assistant
Sep 10, 2026, 10:05 ET Water Wings Swim School Opens First Franchised Location, Accelerating National Growth with 54-Unit Pipeline
six franchised Water Wings Swim Schools expected to open in 2026. The next location, owned by Ali Robaei, is scheduled to open in Frisco, TX, on September 19. Additional schools are expected to open in Arlington, TX, Billings, MT, Brighton, MI and Marysville, WA by the end of the year.Water
More news about: Water Wings Swim School
Sep 10, 2026, 10:05 ET Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
of Kos Biotechnology Partners. "I have known Michael personally and professionally for over a decade and I couldn't be more excited about having him on our team. I am confident that his deep scientific insight and operational experience will be invaluable to Kos as we continue to build and back high-impact
More news about: Kos Biotechnology Partners
Sep 10, 2026, 10:04 ET Insurance Expert Merrie Connon Highlights Homeowners Insurance Needs Beyond Basic Coverage in HelloNation
overlooked, is another essential part of homeowners' insurance. The article notes that this coverage protects against accidents or injuries that happen on the property. Tucson homeowners with pets, pools, or frequent visitors may benefit from higher liability limits to reduce the risk of legal or medical
More news about: HelloNation
Sep 10, 2026, 10:03 ET Intellezy Named to Training Industry's 2026 Top Online Learning Library Companies Watch List
Creative Cloud, and business skills including leadership, communication, and cybersecurity.The library is refreshed on an ongoing basis as software changes, so training on fast-moving tools stays current with the version employees are actually using. Content is available in more than 40 languages.The
More news about: Intellezy
Sep 10, 2026, 10:03 ET Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform
will focus on the device's wireless and radio-frequency performance in real hospital environments, including its antenna and power systems, and the advanced engineering required to move the sleeve toward what is expected to be significant manufacturing volumes.The STTR award builds on earlier support
More news about: Senphonix, Inc.
Sep 10, 2026, 10:01 ET Biological Safety Cabinet Market worth $0.36 billion by 2031 - Exclusive Report by MarketsandMarkets™
emphasis on certified containment systems, are expected to sustain demand for Class II biological safety cabinets during the forecast period.Pharma & biopharma organizations to register the highest CAGR in the biological safety cabinet market from 2026 to 2031.Based on end user,
More news about: MarketsandMarkets
Sep 10, 2026, 10:00 ET Momcozy and NIQ Release New Report on Modern Motherhood, Introducing "Mom, and More"
maternal care—one designed around moms' physical needs, time, emotional well-being and evolving lives, while supporting them as they define what comes next on their own terms.To learn more about Momcozy and its commitment to supporting moms, visit
More news about: Momcozy
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bally's Corporation - BALY
facility. On this news, Bally's stock price fell $3.68 per share, or 26.3%, to close at $10.31 per share on August 17, 2026. Then, on September 3, 2026, Bally's announced the resignation of its Chief Financial Officer, effective immediately, citing "personal reasons." On this news, Bally's
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
action]On August 24, 2026, Azenta issued a press release announcing the resignation of John Marotta from his roles as Chief Executive Officer and as a director of the Company. On this news, Azenta's stock price fell $4.52 per share, or 12.09%, to close at $32.88 per share on August 24, 2026.Pomerantz
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baidu, Inc. - BIDU
in Legacy Business, partially offset by an increase in Baidu Core AI-powered Business." On this news, Baidu's ADS price fell $7.50, or 5.65%, to close at $125.15 on February 26, 2026. Then, on August 18, 2026, the Company reported second quarter 2026 financial results, including revenue
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wolfspeed, Inc. - WOLF
loss of $2.26 per share, significantly worse than the consensus estimate of $0.52 per share. On this news, Wolfspeed's stock price fell $2.74 per share, or 9.42%, to close at $26.35 per share on August 20, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Criteo S.A. - CRTO
action]On August 5, 2026, Criteo reported its financial results for the second quarter of 2026. Criteo reported an 11% year-over-year decline in revenue and net income down 49% against the same period. The Company also announced a change in its Chief Financial Officer. On this new, Criteo's
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
2 mg aflibercept (Regeneron Pharmaceuticals' (REGN) Eylea) was not met in the entire dataset. On this news, EyePoint's stock price fell $9.88 per share, or 66.98%, to close at $4.87 per share on August 17, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
information about joining the class action]On August 5, 2026, Emergent reported results for the quarter ended June 30, 2026. Among other items, Emergent announced, among other things, a $191.3 million non-cash impairment charge on the NARCAN asset group, driving a GAAP net loss of $180.2
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lincoln Educational Services Corp.- LINC
new student starts occurred "basically system-wide" and "across the board . . . by program." On this news, Lincoln's stock price fell $10.22 per share, or 24.93%, to close at $30.77 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION
sweat chloride when SION-719 was administered alongside the standard-of-care treatment Trikafta. On this news, Sionna's stock price fell $46.54 per share, or 91.18%, to close at $4.50 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
the Company's payer mix, which impacted revenue by approximately $400 million in the quarter. On this news, HCA's stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
action]On August 20, 2026, OSI reported fiscal fourth-quarter and full-year 2026 financial results, including revenue that fell short of consensus expectations. OSI attributed the revenue miss to deferred product deliveries stemming from site constraints. On this news, OSI's stock
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qfin Holdings, Inc. - QFIN
funding costs and systemic liquidity shocks in the Chinese consumer credit market. On this news, Qfin's American Depositary Receipt ("ADR") price fell $2.18 per ADR, or 18.91%, to close at $9.35 per ADR on August 26, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Klarna Group plc - KLAR
[Click here for information about joining the class action]On or around September 10, 2025, Klarna completed its initial public offering ("IPO"), selling 34.3 million shares priced at $40.00. Then, on August 18, 2026, Klarna announced its financial results for the second quarter
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
social-media commentary, softer-than-planned new-product launches, and weaker store traffic. On this news, lululemon's stock price fell $21.16 per share, or 17.38%, to close at $100.61 per share on September 4, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FuelCell Energy, Inc. - FCEL
certain inventory to net realizable value and approximately $13 million for losses on firm purchase commitments. On this news, FuelCell's stock price fell $2.68 per share, or 15.69%, to close at $14.40 per share on September 2, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles,
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("Lenz" or the "Company") (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Sep 10, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
[Click here for information about joining the class action]On August 13, 2026, Abeona issued a press release "report[ing] financial results for the second quarter of 2026 and provid[ing] an update on commercial execution for ZEVASKYN (prademagene zamikeracel)." Abeona disclosed
More news about: Pomerantz LLP